Ferrostatin-1-Loaded Gelatin Methacryloyl Hydrogel Improves Random-Pattern Skin Flap Survival by Preserving Nfe2l2/Gpx4 Ferroptosis Defense in Rats

ferrostatin-1 GelMA random-pattern skin flap ferroptosis Nfe2l2 Gpx4 RT-qPCR veterinary reconstructive surgery

Authors

November 4, 2026

Downloads

Background: Distal necrosis remains a limiting complication of random-pattern skin flaps. Ferroptotic lipid damage can amplify ischemia-reperfusion injury, whereas ferrostatin-1 suppresses lipid-radical propagation. A local hydrogel depot may maintain drug near the vulnerable flap bed and avoid repeated systemic administration. Methods: Forty male Sprague-Dawley rats underwent a standardized 3 × 9 cm caudally based dorsal random-pattern flap and were randomized to vehicle, blank 10% gelatin methacryloyl (GelMA), free ferrostatin-1 (1 µg), or ferrostatin-1-loaded GelMA (1 µg). GelMA formulations contained 0.05% LAP and were crosslinked for 30 s with calibrated 405-nm light at 8-12 mW/cm². Day-7 viable flap area, serial laser-Doppler perfusion, Nfe2l2 and Gpx4 RT-qPCR, tissue MDA/GSH, H&E injury and CD31-positive vessel density were quantified under concealed codes. Results: Fer-1@GelMA produced the greatest day-7 viable flap area (83.8 ± 4.1%) compared with free Fer-1 (71.8 ± 3.3%), blank GelMA (64.0 ± 4.2%) and vehicle (57.0 ± 4.9%; ANOVA P<0.001). Perfusion showed a significant treatment×day interaction (GEE P=0.0044). Fer-1@GelMA increased Nfe2l2 and Gpx4 expression to 2.77- and 2.93-fold, lowered MDA, increased GSH, increased CD31-positive vessel density and reduced histologic injury. Conclusion: Local ferrostatin-1 delivery in GelMA produced the strongest preservation of flap viability and microvascular perfusion, with coordinated activation of Nfe2l2/Gpx4-associated antioxidant defense and suppression of lipid peroxidation.